La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Luyan PharmaLtd Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.0B and total debt of CN¥4.9B, which brings its debt-to-equity ratio to 162.3%. Its total assets and total liabilities are CN¥12.0B and CN¥9.0B respectively. Luyan PharmaLtd's EBIT is CN¥695.4M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥458.1M.
Informazioni chiave
162.3%
Rapporto debito/patrimonio netto
CN¥4.94b
Debito
| Indice di copertura degli interessi | 3.2x |
| Contanti | CN¥458.14m |
| Patrimonio netto | CN¥3.04b |
| Totale passività | CN¥8.98b |
| Totale attività | CN¥12.02b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 002788's short term assets (CN¥9.5B) exceed its short term liabilities (CN¥8.2B).
Passività a lungo termine: 002788's short term assets (CN¥9.5B) exceed its long term liabilities (CN¥798.0M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 002788's net debt to equity ratio (147.2%) is considered high.
Riduzione del debito: 002788's debt to equity ratio has reduced from 174.2% to 162.3% over the past 5 years.
Copertura del debito: 002788's debt is well covered by operating cash flow (22.1%).
Copertura degli interessi: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).